Seminars in Nuclear Medicine
Volume 40, Issue 5 , Pages 317-318 , September 2010

Letter from the Editors: Clinical Trials in Nuclear Medicine

References 

  1. Patton D. Introduction to clinical decision making. Semin Nucl Med. 2010;40:319–326
  2. Graham MM. The Clinical Trials Network of the Society of Nuclear Medicine. Semin Nucl Med. 2010;40:327–331
  3. Rollo D, Machado S, Ceschin M. Design of clinical trials. Semin Nucl Med. 2010;40:332–337
  4. Seibyl J, Marek K, Zubal IG. The role of the core imaging laboratory in multicenter trials. Semin Nucl Med. 2010;40:338–346
  5. Norenberg JP, Petry NA, Schwarz S. Operation of a radiopharmacy for a clinical trial. Semin Nucl Med. 2010;40:347–356
  6. Wassertheil-Smoller S, Kim MY. Statistical analysis of clinical trials. Semin Nucl Med. 2010;40:357–363
  7. Harapanhalli RS. FDA requirements for testing and approval of new radiopharmaceuticals. Semin Nucl Med. 2010;40:364–384
  8. Hart R, Belotto M. The Institutional Review Board. Semin Nucl Med. 2010;40:385–392

PII: S0001-2998(10)00048-6

doi: 10.1053/j.semnuclmed.2010.06.001

Seminars in Nuclear Medicine
Volume 40, Issue 5 , Pages 317-318 , September 2010

Article Tools